# Study to Evaluate SID 530 Compared to Taxotere

> **NCT00931008** · PHASE3 · COMPLETED · sponsor: **SK Chemicals Co., Ltd.** · enrollment: 42 (actual)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** SID530, Taxotere

## Key facts

- **NCT ID:** NCT00931008
- **Lead sponsor:** SK Chemicals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2013-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00931008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00931008, "Study to Evaluate SID 530 Compared to Taxotere". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00931008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*